Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K W Renton

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Clinical Biochemistry|April 1, 1986
Factors affecting drug biotransformationK W Renton
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1979
The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoinK W Renton
Biochemical Pharmacology|July 15, 1985
Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamilK W Renton
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1980
Methyl red azo-reductase and its induction by 3-methylcholanthrene in the liver by different speciesK W Renton
Biochemical Pharmacology|August 15, 1981
Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virusK W Renton
Seminars in Perinatology|October 1, 1981
Effects of infection and immune stimulation on theophylline metabolismK W Renton
Pharmacology & Therapeutics|March 28, 2002
Alteration of drug biotransformation and elimination during infection and inflammationK W Renton
Toxicology|February 10, 2000
Hepatic drug metabolism and immunostimulationK W Renton
Toxicology and Applied Pharmacology|January 1, 1984
The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC)K W Renton, G Dickson
Life Sciences|January 1, 1997
Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta inductionE Delaporte, K W Renton
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Clinical Biochemistry|April 1, 1986
Factors affecting drug biotransformationK W Renton
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1979
The deleterious effect of Bordetella pertussis vaccine and poly(rI.rC) on the metabolism and disposition of phenytoinK W Renton
Biochemical Pharmacology|July 15, 1985
Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamilK W Renton
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1980
Methyl red azo-reductase and its induction by 3-methylcholanthrene in the liver by different speciesK W Renton
Biochemical Pharmacology|August 15, 1981
Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virusK W Renton
Seminars in Perinatology|October 1, 1981
Effects of infection and immune stimulation on theophylline metabolismK W Renton
Pharmacology & Therapeutics|March 28, 2002
Alteration of drug biotransformation and elimination during infection and inflammationK W Renton
Toxicology|February 10, 2000
Hepatic drug metabolism and immunostimulationK W Renton
Toxicology and Applied Pharmacology|January 1, 1984
The prevention of acetaminophen-induced hepatotoxicity by the interferon inducer poly(rI . rC)K W Renton, G Dickson
Life Sciences|January 1, 1997
Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta inductionE Delaporte, K W Renton
Pageof 9